In vitro cytotoxicity of eight β-blockers in human corneal epithelial and retinal pigment epithelial cell lines: Comparison with epidermal keratinocytes and dermal fibroblasts

Toxicology in Vitro

Volumn 22, Issue 4, 2008, Pages 1070-1076

  Cheong, Hoi I ^a   Johnson, Juanita ^a   Cormier, Michel ^a   Hosseini, Kamran ^a  

^a ALZA CORPORATION   (United States)

Author keywords

Blockers; ARPE 19; CRL 11515; Cytotoxicity; Glaucoma; HCEpiC; HRPEpiC; Human corneal epithelial cell line; Human fibroblasts; Human keratinocytes; Human retinal pigment epithelial cell line

Indexed keywords

ALPRENOLOL; ATENOLOL; BISOPROLOL; LABETALOL; METOPROLOL; PINDOLOL; PROPRANOLOL; TIMOLOL;

ARTICLE; BIOCOMPATIBILITY; CALCULATION; CELL LINE; CELL SPECIFICITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA EPITHELIUM; CYTOTOXICITY; DRUG POTENCY; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; KERATINOCYTE; PIGMENT EPITHELIUM;

ADRENERGIC BETA-ANTAGONISTS; CELL LINE; EPIDERMIS; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; FIBROBLASTS; HUMANS; KERATINOCYTES; PIGMENT EPITHELIUM OF EYE; SKIN; TOXICITY TESTS;

EID: 41949134291     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2008.01.013     Document Type: Article

References (30)

1. Acheampong A.A., Breau A., Shackleton M., Luo W., Lam S., and Tang-Liu D.D. Comparison of concentration-time profiles of levobunolol and timolol in anterior and posterior ocular tissues of albino rabbits. Journal of Ocular Pharmacology and Therapeutics 11 (1995) 489-502
2. Belpaire F.M., Bogaert M.G., and Rosseneu M. Binding of β-adrenoceptor blocking drugs to human serum albumin, to α1-acid glycoprotein and to human serum. European Journal of Clinical Pharmacology 22 (1982) 253-256
3. Bonomi L., Perfetti S., Bellucci R., Massa F., and Noya E. Ocular hypotensive action of labetalol in rabbit and human eyes. Graefe's Archive for Clinical and Experimental Ophthalmology 217 (1981) 175-181
4. Borenfreund E., and Borrero O. In vitro cytotoxicity assays. Potential alternatives to the Draize ocular allergy test. Cell Biology and Toxicology 1 (1984) 55-65
5. Bracher M., Faller C., Spengler J., and Reinhardt C.A. Comparison of in vitro cell toxicity with in vivo eye irritation. Molecular Toxicology 1 Fall (1987) 561-570
6. Brooks A.M., and Gillies W.E. Ocular beta-blockers in glaucoma management. Clinical Pharmacological Aspects. Drugs Aging 2 (1992) 208-221
7. Burgalassi S., Chetoni P., Monti D., and Saettone M.F. Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines. Toxicology Letters 122 (2001) 1-8
8. Frishman W.H., Fuksbrumer M.S., and Tannenbaum M. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension. Journal of Clinical Pharmacology 34 (1994) 795-803
9. Grant R.L., Yao C., Gabaldon D., and Acosta D. Evaluation of surfactant cytotoxicity potential by primary cultures of ocular tissues: I. Characterization of rabbit corneal epithelial cells and initial injury and delayed toxicity studies. Toxicology 76 (1992) 153-176
10. Gross R.L., Hensley S.H., Gao F., and Wu S.M. Retinal ganglion cell dysfunction induced by hypoxia and glutamate: potential neuroprotective effects of beta-blockers. Survey of Ophthalmology 43 (1999) S162-S170
11. Gurbay A., Gonthier B., Barret L., Favier A., and Hincal F. Cytotoxic effect of ciprofloxacin in primary culture of rat astrocytes and protection by Vitamin E. Toxicology 229 (2007) 54-61
12. Hornof M., Toropainen E., and Urtti A. Cell culture models of the ocular barriers. European Journal of Pharmaceutics and Biopharmaceutics 60 (2005) 207-225
13. Kida T., Sugiyama T., Harino S., Kitanishi K., and Ikeda T. The effect of nipradilol, an alpha-beta blocker, on retinal blood flow in healthy volunteers. Current Eye Research 23 (2001) 128-132
14. Lowe M.D., Lynham J.A., Grace A.A., and Kaumann A.J. Comparison of the affinity of beta-blockers for two states of the 1-adrenoceptor in ferret ventricular myocardium. British Journal of Pharmacology 135 (2002) 451-461
15. Melena J., and Osborne N.N. Metipranolol attenuates lipid peroxidation in rat brain: a comparative study with other antiglaucoma drugs. Graefe's Archive for Clinical and Experimental Ophthalmology 241 (2003) 827-833
16. North-Root H., Yackovich F., Demetrulias J., Gacula M., Heinze J.E., and Gacula Jr. M. Prediction of the eye irritation potential of shampoos using the in vitro SIRC cell toxicity test. Food and Chemical Toxicology 23 (1985) 271-273
17. Onoa R., Kakehashia A., Itoa Y., Sugia N., Makinoc S., Kobayashid E., Hakamadad Y., Takagie Y., Kitazumee Y., and Kawakamib M. Effect of topical nipradilol on retinal microvascular leukocyte adhesion in diabetic rats. Ophthalmic Research 38 (2006) 270-273
18. Osborne N.N., and Wood J.P.M. Metipranolol blunts nitric-induced lipid peroxidation and death of retinal photoreceptors: a comparison with other anti-glaucoma drugs. Investigative Ophthalmology & Visual Science 45 (2004) 3787-3795
19. Osborne N.N., and Wood J.P.M. The β-adrenergic receptor antagonist metipranolol blunts zinc-induced photoreceptor and RPE apoptosis. Investigative Ophthalmology & Visual Science 47 (2006) 3178-3186
20. Phillips C.I., Gore S.M., and Gunn P.M. Atenolol versus adrenaline eye drops and an evaluation of these two combined. British Journal of Ophthalmology 62 (1978) 296-301
21. Ros F.E., Dake C.L., Nagelkerke H.J.D., and Greve E.L. Metoprolol eye drops in the treatment of glaucoma a double-blind single-dose trial of a beta1-adrenergic blocking drug. Graefe's Archive for Clinical and Experimental Ophthalmology 206 (1978) 247-254
22. Schoenwald R.D., and Huang H.-S. Corneal penetration behaviour of beta blocking agents I: physiochemical factors. Journal of Pharmaceutical Sciences 72 (1983) 1266-1272
23. Smith R.J., Blamires T., Nagasubramanian S., Watkins R., and Poinoosawmy D. Addition of pindolol to routine medical therapy: a clinical trial. British Journal of Ophthalmology 66 (1982) 102-108
24. Stewart W.C., Stewart J.A., Holmes K.T., and Leech J.N. Differences in ocular surface irritation between timolol hemihydrate and timolol maleate. American Journal of Ophthalmology 130 (2000) 712-716
25. Vale J., Gibbs A.C., and Phillips C.I. Topical propranolol and ocular tension in the human. British Journal of Ophthalmology 56 (1972) 770-775
26. van der Woude H., Alink G.M., and Rietjens I.M. The definition of hormesis and its implications for in vitro to in vivo extrapolation and risk assessment. Critical Reviews in Toxicology 35 (2005) 603-607
27. Vichi P., and Tritton T.R. Stimulation of growth in human and murine cells by adriamycin. Cancer Research 49 (1989) 2679-2682
28. Wang W., Sasaki H., Chien D.S., and Lee V.H.L. Lipophilicity influence on conjunctival drug penetration in the pigmented rabbits: a comparison with corneal penetration. Current Eye Research 10 (1991) 571-579
29. Weinreb R.N. Lowering intraocular pressure to minimize glaucoma damage. Advances in glaucoma therapy. Journal of Glaucoma 10 S1 (2001) 76-77
30. Wood J.P., Schmidt K.G., Melena J., Chidlow G., Allmeier H., and Osborne N.N. The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol. Experimental Eye Research 76 (2003) 505-516